The Course of Incipient and Overt Diabetic Nephropathy: The Perspective of Insulin Pump Treatment

  • Bo Feldt-Rasmussen
Part of the Topics in Renal Medicine book series (TIRM, volume 6)


The long-term objective of insulin treatment of insulin-dependent diabetes mellitus (IDDM) is prevention of late complications. Although never directly proven, it has been a widely accepted hypothesis that development of such microvascular complications is, at least in part, due to the lack of good metabolic control [1, 2]. Since the capacity of most diabetes clinics is at present too small to cope with the enormous task of normalizing or nearly normalizing the metabolic control in all patients, many compromises defining good or acceptable metabolic control have been made while awaiting more rigorous testing of the hypothesis. This testing again had to await the introduction of more intensive treatment regimens, such as multiple insulin injections (injection pens) or insulin infusion pumps combined with new techniques for home blood glucose monitoring. During such regimens, an improved and often “near normal” blood glucose level can be maintained for long periods as documented by measurement of glycosylated hemoglobin, an index of the longterm level of the glycemic control [3–8]. A number of studies, retrospective and prospective, taking advantage of these techniques, have been performed. When reviewing these studies, the general interpretation is that the blood glucose level is in fact important for the development and progression of diabetic microangiopathy in humans [9].


Diabetic Nephropathy Urinary Albumin Excretion Continuous Subcutaneous Insulin Infusion IDDM Patient Conventional Treatment Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tchobroutsky G: Relation of diabetic control to development of microvascular complications. Diabetologia 15: 143–152, 1978.PubMedCrossRefGoogle Scholar
  2. 2.
    Pirart J: Diabetes mellitus and its degeneration complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1:168–168 and 252–263, 1978.Google Scholar
  3. 3.
    Mecklenburg RS, Benson EA, Benson JW, et al: Long-term metabolic control with insulin pump therapy. N Engl J Med 313: 465–468, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Steno Study Group: Two years’ experience of continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes [Suppl] 34: 74–79, 1985.Google Scholar
  5. 5.
    Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic nephropathy and albuminuria. N Engl J Med 311: 365–372, 1984.CrossRefGoogle Scholar
  6. 6.
    Dahl Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenæs Ø, Aker Diabetes Group: Rapid tightening of retinopathy of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus. Br Med J 190: 811–815, 1985.CrossRefGoogle Scholar
  7. 7.
    Beck-Nielsen H, Richelsen B, Mogensen CE, et al.: Effect of insulin pump treatment for one year on renal function-and retinal morphology in patients with IDDM. Diabetes Care 8: 585–589, 1985.Google Scholar
  8. 8.
    Feldt-Rasmussen B, Mathiesen ER, Hegedus L, Deckert T: Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med 314: 665–670, 1986.PubMedCrossRefGoogle Scholar
  9. 9.
    Hanssen KF, Dahl Jorgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T: Diabetic control and microvascular complications: the near-normoglycemic experience. Diabetologia 29: 677–684, 1986.PubMedCrossRefGoogle Scholar
  10. 10.
    Bohman SO, Tydén G, Wilczek H, Lundgren G, Jaremko G, Gunnarson R, Ostman J, Groth CG: Prevention of kidney graft: diabetic nephropathy by pancreas transplantation in man. Diabetes 34: 306–308, 1985.PubMedCrossRefGoogle Scholar
  11. 11.
    Abouna GM, Kremer GD, Daddah SK, Al-Adnani MS, Kumar SA, Kusma G: Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into nondiabetic recipients. Lancet 2: 1274–1276, 1983.PubMedCrossRefGoogle Scholar
  12. 12.
    Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H: Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J 286: 598602, 1983.Google Scholar
  13. 13.
    Christiansen JS, Parving H-H: The effect of short term strict metabolic control on albuminuria in insulin-dependent diabetics with normal kidney function and diabetic nephropathy. Diabetic Nephropathy 3: 127–129, 1984.Google Scholar
  14. 14.
    Bending JJ, Viberti GC, Watkins PJ, Keen H: Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med.) 292: 83–86, 1986.CrossRefGoogle Scholar
  15. 15.
    Parving HH, Noer I, Deckert T, Errin PE, Nielsen SL, Lyngsoe J, Mogensen CE, Rorth M, Svendsen PA, Trap Jensen J, Lassen NA: The effect of metabolic regulation on microvascular permeability to small and large molecules in short term juvenile diabetics. Disbetologia 12: 161–166, 1976.CrossRefGoogle Scholar
  16. 16.
    Viberti GC, Pickup JC, Jarrett RJ, Keen H: Effect of control of blood glucose on urinary excretion of albumin and beta2-microglobulin in insulin-dependent diabetes. N Engl J Med 300: 638–641, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Deckert T, Lauritzen T, Parving HH, Christiansen JS, Steno Study Group: Effect of two years of strict metabolic control on kidney function in long-term insulin-dependent diabetes. Diabetic Nephropathy 3: 6–10, 1984.Google Scholar
  18. 18.
    Feldt-Rasmussen B, Mathiesen ER: Variability of urinary albumin excretion in incipient diabetic nephropathy. Diabetic Nephropathy 3: 101–103, 1984.Google Scholar
  19. 19.
    Dahl Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes Ø: Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo study. Br Med..] 293: 1195–1199, 1986.CrossRefGoogle Scholar
  20. 20.
    Feldt-Rasmussen B, Mathiesen ER, Deckert T: Effect on the progression of diabetic renal disease during 2 years of strict metabolic control in insulin-dependent diabetes. Lancet 2: 1300 1304, 1986.Google Scholar
  21. 21.
    Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596, 1985.PubMedCrossRefGoogle Scholar
  22. 22.
    Lauritzen T: Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy [thesis]. Copenhagen: Laegeforeningen, 1985.Google Scholar
  23. 23.
    Mecklenburg RS, Benson EA, Benson JW, Fredlund PN, Guinn T, Metz RJ, Nielsen RL, Sonnar CA: Acute complications associated with insulin infusion pump therapy. JAMA 252: 3265–3269, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Bo Feldt-Rasmussen

There are no affiliations available

Personalised recommendations